Skip to main content
SpringerLink
Log in

Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Head and neck cancer patients treated with high-dose cisplatin and radiotherapy will suffer from hearing deficits. The current low-dose regimen seldom causes hearing threshold decrease. Tinnitus in this patient population has not been investigated earlier. We aimed to evaluate the possible ototoxicity of low-dose (40 mg/m2) weekly administered cisplatin with concomitant radiotherapy. Twenty-two patients with locally advanced head and neck cancer were prospectively recruited to participate the study after treatment recommendation for chemoradiotherapy with low-dose cisplatin and intensity-modulated radiotherapy. They filled in a Tinnitus Handicap Inventory and undertook audiologic evaluations before and after treatment. Ototoxicity was determined by >10 dB threshold shift at frequencies 4 and 8 kHz or in pure tone average. A historical cohort of nine patients treated with high-dose (100 mg/m2) cisplatin and radiotherapy was used for comparison. After treatment, study patients demonstrated no significant changes in their hearing over frequencies 0.5–4 kHz, and the threshold shifts were minor at 4 and 8 kHz. More than 50 % of patients reported no tinnitus after treatment and the remainder only had slight to moderate tinnitus causing no interference with their daily activities. In contrast, five of the nine patients having received high-dose cisplatin reported disturbing tinnitus. Further, changes in pure tone averages were exhibited in three of these patients and six had significant threshold shifts at 4 and 8 kHz. Head and neck cancer patients treated with concomitant intensity-modulated radiotherapy and low-dose cisplatin seem to experience only minor audiological sequelae and therefore, these patients appear to require no routine audiological monitoring. Such evaluation could be performed only when needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Verellen D, Linthout N, Berge DVD, Bel A, Storme G (1997) Initial experience with intensity-modulated conformal radiation therapy for treatment of the head and neck region. Int J Radiat Oncol Biol Phys 39:99–114

    Article  CAS  PubMed  Google Scholar 

  2. Lee N, Puri DR, Blanco AI, Chao KS (2007) Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck 29(4):387–400

    Article  PubMed  Google Scholar 

  3. Saarilahti K, Kouri M, Collan J, Hämäläinen T, Atula T, Joensuu H, Tenhunen M (2005) Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 74:251–258

    Article  PubMed  Google Scholar 

  4. Saarilahti K, Kouri M, Collan J, Kangasmäki A, Atula T, Joensuu H, Tenhunen M (2006) Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 78(3):270–275

    Article  PubMed  Google Scholar 

  5. Loimu V, Collan J, Vaalavirta L, Bäck L, Kapanen M, Mäkitie A, Tenhunen M, Saarilahti K (2011) Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin. Radiother Oncol 98(1):34–37

    Article  CAS  PubMed  Google Scholar 

  6. Marshall NE, Ballman KV, Michalak JC, Schomberg PJ, Burton GV, Sandler HM, Cascino TL, Jaeckle KA, Buckner JC (2006) Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients. J Neurooncol 77(3):315–320

    Article  CAS  PubMed  Google Scholar 

  7. Reavis KM, McMillan G, Austin D, Gallun F, Fausti SA, Gordon JS, Helt WJ, Konrad-Martin D (2011) Distortion-product otoacoustic emission test performance for ototoxicity monitoring. Ear Hear 32(1):61–74

    Article  PubMed  Google Scholar 

  8. Cardinaal RM, de Groot JCMJ, Huizing EH, Veldman JE, Smoorenburg GF (2000) Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hear Res 144(1–2):135–146

    Article  CAS  PubMed  Google Scholar 

  9. Theunissen EA, Zuur CL, Bosma SC, Lopez-Yurda M, Hauptmann M, van der Baan S, de Boer JP, van der Molen L, Rasch CR, Dreschler WA, Balm AJ (2014) Long-term hearing loss after chemoradiation in patients with head and neck cancer. Laryngoscope 124(12):2720–2725

    Article  PubMed  Google Scholar 

  10. Langenberg M, Terhaard CH, Hordijk GJ, Es RJ, Voest EE, Graeff A (2004) Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital. Clin Otolaryngol Allied Sci 29(6):729–734

    Article  CAS  PubMed  Google Scholar 

  11. Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC (2009) Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 73(3):779–788

    Article  CAS  PubMed  Google Scholar 

  12. Rades D, Fehlauer F, Sheikh-Sarraf M, Kazic N, Basic H, Poorter R, Hakim SG, Schild SE, Dunst J (2008) Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer. Head Neck 30(2):235–241

    Article  PubMed  Google Scholar 

  13. Pearson SE, Meyer AC, Adams GL, Ondrey FG (2006) Decreased hearing after combined modality therapy for head and neck cancer. Am J Otolaryngol 27(2):76–80

    Article  PubMed  Google Scholar 

  14. Low WK, Toh ST, Wee J, Fook-Chong SM, Wang DY (2006) Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study. J Clin Oncol 24(12):1904–1909

    Article  PubMed  Google Scholar 

  15. Newman CW, Jacobson GP, Spitzer JB (1996) Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg 122:143–148

    Article  CAS  PubMed  Google Scholar 

  16. Zeman F, Koller M, Figueiredo R, Aazevedo A, Rates M, Coelho C, Kleinjung T, de Ridder D, Langguth B, Landgrebe M (2011) Tinnitus handicap inventory for evaluating treatment effects: which changes are clinically relevant? Otolaryngol Head Neck Surg 145(2):282–287

    Article  PubMed  Google Scholar 

  17. Zuur CL, Simis YJ, Lansdaal PE, Rasch CR, Tange RA, Balm AJ, Dreschler WA (2006) Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer. Audiol Neurootol 11(5):318–330

    Article  CAS  PubMed  Google Scholar 

  18. Kaltenbach JA, Rachel JD, Mathog TA, Zhang J, Falzarano PR, Lewandowski M (2002) Cisplatin-induced hyperactivity in the dorsal cochlear nucleus and its relation to outer hair cell loss: relevance to tinnitus. J Neurophysiol 88(2):699–714

    CAS  PubMed  Google Scholar 

  19. Rachel JD, Kaltenbach JA, Janisse J (2002) Increases in spontaneous neural activity in the hamster dorsal cochlear nucleus following cisplatin treatment: a possible basis for cisplatin-induced tinnitus. Hear Res 164(1–2):206–214

    Article  CAS  PubMed  Google Scholar 

  20. Bauer CA, Brozoski TJ (2005) Cochlear structure and function after round window application of ototoxins. Hear Res 201(1–2):121–131

    Article  CAS  PubMed  Google Scholar 

  21. Theunissen EA, Bosma SC, Zuur CL, Spijker R, van der Baan S, Dreschler WA, de Boer JP, Balm AJ, Rasch CR (2015) Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature. Head Neck 37(2):281–292

    Article  PubMed  Google Scholar 

  22. American Speech-Language-Hearing Association (1994) Audiologic management of individuals receiving cochleotoxic drug therapy. ASHA 36(suppl 12):11–19

    Google Scholar 

  23. Simpson TH, Schwan SA, Rintelmann WF (1992) Audiometric test criteria in the detection of cisplatin ototoxicity. J Am Acad Audiol 3(3):176–185

    CAS  PubMed  Google Scholar 

  24. Konrad-Martin D, James KE, Gordon JS, Reavis KM, Phillips DS, Bratt GW, Fausti SA (2010) Evaluation of audiometric threshold shift criteria for ototoxicity monitoring. J Am Acad Audiol 21(5):301–314

    Article  PubMed  Google Scholar 

  25. Konrad-Martin D, Gordon JS, Reavis KM, Wilmington DJ, Helt EJ, Fausti SA (2005) Perspectives on hearing and hearing disorders: research and diagnostics 9(1):17–22

  26. Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G (2001) Evoked otoacoustic emissions–an approach for monitoring cisplatin induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 59(1):47–57

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Helsinki University Hospital Research Fund, Finland.

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Head and Neck Surgery, University of Helsinki and Helsinki University Hospital (HUH), P.O.Box 220, 00029, Helsinki, Finland

    Riina Niemensivu, A. Aarnisalo & A. A. Mäkitie

  2. Department of Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

    K. Saarilahti

  3. Helsinki Ear Institute, Helsinki, Finland

    J. Ylikoski

  4. Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska Hospital, Stockholm, Sweden

    A. A. Mäkitie

Authors
  1. Riina Niemensivu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Saarilahti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Ylikoski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Aarnisalo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. A. Mäkitie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Riina Niemensivu.

Ethics declarations

Conflict of interest

No conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Niemensivu, R., Saarilahti, K., Ylikoski, J. et al. Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy. Eur Arch Otorhinolaryngol 273, 2509–2514 (2016). https://doi.org/10.1007/s00405-015-3857-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-015-3857-5

Keywords

Search

Navigation